Genetic variability of human adenovirus type 7 circulating in mainland China.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 07 02 2020
accepted: 07 04 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 21 7 2020
Statut: epublish

Résumé

Human adenovirus (HAdV-7) is a highly contagious pathogen that causes severe respiratory illnesses. However, the epidemic patterns and genetic variability of HAdV-7 circulating in mainland China have not been well elucidated. In this study, we used Chinese HAdV sentinel surveillance data obtained from 2012-2015 to investigate the clinical features of 122 HAdV-7-positive cases and performed amplification and sequence determination of three capsid genes (penton base, hexon, and fiber) from 69 isolated viruses covering from seven provinces of China. Additionally, we compared with data from representative sequences of 21 strains covering seven more provinces in China and 32 international HAdV-7 strains obtained from GenBank database to determine the phylogenetic, sequence variations, and molecular evolution of HAdV-7. The results indicated that HAdV-7 infection occurred throughout the year, and a high proportion of severe cases (27 cases, 22.1%) exhibited infantile pneumonia. Moreover, phylogenetic analysis showed that all HAdV-7 strains could be divided into two major evolutionary branches, including subtype 1 and subtype 2, and subtype 3 was also formed according to analysis of the penton base gene. Subtypes 1 and 2 co-circulated in China before 2008, and HAdV-7 strains currently circulating in China belonged to subtype 2, which was also the predominant strain circulating worldwide in recent years. Further sequence variation analysis indicated that three genes of HAdV-7 were relatively stable across time and geographic space, particularly for viruses within subtypes, which shared almost the same variation sites. Owing to continuous outbreaks caused by HAdV-7, resulting in increased illness severity and fatality rates in China, the establishment of a national HAdV surveillance system is urgently needed for the development of effective preventive and infection-control interventions for adenovirus respiratory infections in China.

Identifiants

pubmed: 32352995
doi: 10.1371/journal.pone.0232092
pii: PONE-D-20-03625
pmc: PMC7192419
doi:

Substances chimiques

Capsid Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232092

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Virol. 2006 Apr;35(4):388-93
pubmed: 16458589
Microbiol Immunol. 2013 Aug;57(8):553-60
pubmed: 23734976
J Clin Microbiol. 2002 Jan;40(1):140-5
pubmed: 11773107
Emerg Infect Dis. 2005 May;11(5):649-54
pubmed: 15890114
Influenza Other Respir Viruses. 2014 May;8(3):302-8
pubmed: 24467816
Sci Rep. 2016 Nov 16;6:37216
pubmed: 27848998
J Gen Virol. 2003 Nov;84(Pt 11):2895-2908
pubmed: 14573794
Genome Announc. 2013 Jan;1(1):
pubmed: 23409258
Arch Virol. 2015 Mar;160(3):633-8
pubmed: 25504360
Emerg Infect Dis. 2016 Apr;22(4):730-3
pubmed: 26982199
Sci Rep. 2014 Dec 08;4:7365
pubmed: 25482188
Am J Transl Res. 2016 May 15;8(5):2331-42
pubmed: 27347341
Virol J. 2011 Jan 18;8:23
pubmed: 21241515
J Clin Microbiol. 2004 Apr;42(4):1686-93
pubmed: 15071026
Virology. 2010 Feb 5;397(1):113-8
pubmed: 19932910
Open Forum Infect Dis. 2019 Jan 11;6(2):ofz017
pubmed: 30800698
J Clin Microbiol. 2003 Oct;41(10):4594-9
pubmed: 14532188
Chin Med J (Engl). 1989 Nov;102(11):857-61
pubmed: 2561554
Curr Top Microbiol Immunol. 1995;199 ( Pt 1):163-200
pubmed: 7555054
Emerg Infect Dis. 2012 Nov;18(11):1825-32
pubmed: 23092602
Emerg Infect Dis. 2012 May;18(5):852-4
pubmed: 22515984
PLoS One. 2013 May 14;8(5):e64254
pubmed: 23691184
BMC Infect Dis. 2019 Jan 9;19(1):36
pubmed: 30626350
J Med Virol. 1996 Jul;49(3):170-7
pubmed: 8818961
Virology. 2005 Feb 5;332(1):114-29
pubmed: 15661145
Int J Clin Exp Med. 2015 Sep 15;8(9):15011-7
pubmed: 26628985
Emerg Infect Dis. 2016 Jun;22(6):1044-51
pubmed: 27191834
Emerg Infect Dis. 2002 Mar;8(3):269-77
pubmed: 11927024
Sci Rep. 2015 Sep 04;5:13617
pubmed: 26338697
PLoS One. 2015 Mar 27;10(3):e0121375
pubmed: 25816320
Emerg Microbes Infect. 2018 Feb 7;7(1):10
pubmed: 29410402
Virus Genes. 2014 Aug;49(1):22-9
pubmed: 24760574
Infect Genet Evol. 2019 Dec;76:104035
pubmed: 31505276
J Virol. 1986 Oct;60(1):331-5
pubmed: 3018298
PLoS One. 2015 May 18;10(5):e0127377
pubmed: 25992619

Auteurs

Ru Cai (R)

Medical School, Anhui University of Science and Technology, Huainan city, Anhui province, People's Republic of China.

Naiying Mao (N)

NHC Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

Jingjing Dai (J)

Medical School, Anhui University of Science and Technology, Huainan city, Anhui province, People's Republic of China.
Department of Medical Laboratory, the Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an city, Jiangsu province, People's Republic of China.

Xingyu Xiang (X)

Hunan Provincial Center for Disease Control and Prevention, Changsha city, Hunan province, People's Republic of China.

Jing Xu (J)

Shaanxi Provincial Center for Disease Control and Prevention, Xi'an city, Shaanxi province, People's Republic of China.

Yingwei Ma (Y)

Changchun Children's Hospital, Changchun city, Jilin province, People's Republic of China.

Zhong Li (Z)

Shandong Provincial Center for Disease Control and Prevention, Jinan city, Shandong province, People's Republic of China.

Guangyue Han (G)

Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang city, Hebei province, People's Republic of China.

Deshan Yu (D)

Gansu Provincial Center for Disease Control and Prevention, Lanzhou city, Gansu province, People's Republic of China.

Jie Yin (J)

Yunnan Provincial Center for Disease Control and Prevention, Kunming city, Yunnan province, People's Republic of China.

Aili Cui (A)

NHC Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

Yan Zhang (Y)

NHC Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

Hong Li (H)

Medical School, Anhui University of Science and Technology, Huainan city, Anhui province, People's Republic of China.
The Affiliated Hospital of Southwest Medical University, Luzhou city, Sichuan province, People's Republic of China.

Pengbo Yu (P)

Shaanxi Provincial Center for Disease Control and Prevention, Xi'an city, Shaanxi province, People's Republic of China.

Luyuan Guan (L)

Shaanxi Provincial Center for Disease Control and Prevention, Xi'an city, Shaanxi province, People's Republic of China.

Yuling Tian (Y)

Changchun Children's Hospital, Changchun city, Jilin province, People's Republic of China.

Liwei Sun (L)

Changchun Children's Hospital, Changchun city, Jilin province, People's Republic of China.

Yan Li (Y)

Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang city, Hebei province, People's Republic of China.

Yamei Wei (Y)

Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang city, Hebei province, People's Republic of China.

Zhen Zhu (Z)

NHC Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

Wenbo Xu (W)

Medical School, Anhui University of Science and Technology, Huainan city, Anhui province, People's Republic of China.
NHC Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH